Back to
Janus Henderson Group Ltd.
CTNM5 quarters
Position history for
Janus Henderson Group Ltd.'s holdings in CONTINEUM THERAPEUTICS INC
Yes. Janus Henderson holds 2,734,836 shares of CTNM (Contineum Therapeutics), worth $35.6M, as of its Q1 2026 13F filing. It increased the position by 285,857 shares (+11.7%) from Q4 2025. Janus Henderson has held CTNM since Q4 2025, across 2 quarterly 13F filings.
Current Value
$35.6M
Current Shares
2.7M
Total Value Change
+$34.6M
Total Shares Change
+2.7M
Quarter-by-Quarter History
Other major holders of CTNM: Jupiter Topco LLC, BlackRock, Inc., FRANKLIN TEMPLETON INC, BALYASNY ASSET MANAGEMENT L.P., RA CAPITAL MANAGEMENT, L.P.